IRONWOOD PHARMACEUTICALS, INC. Restricted Cash and Cash Equivalents
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Restricted Cash and Cash Equivalents of $8.31 million as of 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2018-08-06
- 2018-06-30: Restricted Cash and Cash Equivalents $8.31M.
- 2018-03-31: Restricted Cash and Cash Equivalents $7.06M.
- 2017-12-31: Restricted Cash and Cash Equivalents $7.06M.
- 2017-09-30: Restricted Cash and Cash Equivalents $7.06M.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2018-06-30 | $8.31M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $7.06M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $7.06M 10-Q · filed 2018-08-06 | |
| 2017-09-30 | $7.06M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $7.06M 10-Q · filed 2018-08-06 | |
| 2017-03-31 | $8.25M 10-Q · filed 2018-05-04 | $1.19M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $8.25M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |